Medication info
Atoraterol 20 mg (Atorvastatin Calcium Trihydrate)

Atoraterol 20 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›21.69mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201310783 · Approved 2013.12.19 · Insurance code 646003790

Summary

Main use
Improvement of hyperlipidemia and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. As the goal of treatment is to reduce LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.
Child dose
Aged 10 ~ 17 years: The recommended initial dose is 10 mg of this drug daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg of this drug in pediatric patients). The dose should be adjusted as appropriate according to the treatment goals recommended for each patient. Adjust the dose at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
  • homozygous familial hypercholesterolemia
View approved original text

This medication helps to lower the risk of cardiovascular disease. It particularly reduces the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease and in patients with type 2 diabetes. Additionally, it is effective in reducing the risk of non-fatal myocardial infarction, stroke, revascularization procedures, congestive heart failure hospitalization, and angina in patients who already have coronary heart disease. This medication is also used to treat hyperlipidemia, helping to lower bad cholesterol levels and raise good cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It is additionally used in pediatric patients with dyslipidemia and familial hypercholesterolemia who have difficulty controlling their condition through diet. Overall, this medication is used to improve various risk factors for cardiovascular disease and hyperlipidemia.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. As the goal of treatment is to reduce LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.

Child dose

Aged 10 ~ 17 years: The recommended initial dose is 10 mg of this drug daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg of this drug in pediatric patients). The dose should be adjusted as appropriate according to the treatment goals recommended for each patient. Adjust the dose at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle abnormalities, so if severe muscle pain or weakness occurs, or if creatine kinase levels significantly elevate, discontinue use immediately. This medication should not be used in patients with an allergic reaction to it, those with severely impaired liver function, individuals with muscle disorders, pregnant or lactating women, or children under 10 years old. Patients with liver or kidney dysfunction, the elderly, and those at risk of muscle disease should take extra caution while using this medication, and their condition should be regularly monitored. While taking this medication, symptoms such as fatigue, weakness, dyspepsia, headache, dizziness, and skin rash may occur, and if these symptoms are severe, consult a doctor. This medication may interact with other drugs, so be sure to inform your doctor or pharmacist, especially when taking certain antibiotics, antifungals, antivirals, immunosuppressants, colchicine, niacin, etc. Women who are pregnant or planning to become pregnant should ensure appropriate contraception while taking this medication and discontinue use immediately upon confirmation of pregnancy. Nursing women should avoid breastfeeding while taking this medication as it may be harmful to the baby. In case of overdose, there is no specific antidote, so treatment should be symptomatic and liver function and muscle condition should be regularly tested. Keep this medication out of reach of children and store it in its original container to prevent misuse or degradation of quality.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 139 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • oropharyngeal and laryngeal pain
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disturbance
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • neurogenic edema
  • polymorphous erythema
  • blistering dermatitis
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive urine leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • elevated potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • hypertriglyceridemia
  • flushing
  • increased non-protein nitrogen
  • hyperuricemia
  • gingival hypertrophy
  • hypothermia
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • cognitive impairment
  • myasthenia gravis
  • tendon contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequency of urination
  • cystitis
  • hematuria
  • dysuria
  • nephrolithiasis
  • nocturia
  • epididymitis
  • breast fibroadenoma
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical secretions
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency of urination
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • increased appetite
  • vasomotor edema
  • chest pain
  • angina pectoris
  • facial edema
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eye
  • refractive errors
  • ocular hemorrhage
  • auditory loss
  • glaucoma
  • blurred vision
  • taste loss
  • taste disturbance
  • cerebral hemorrhage
  • optic nerve degeneration
  • single episodes of tonic-clonic seizure
  • central nervous system vascular damage

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain storage temperature between 1 and 30 degrees Celsius. Storing it this way will help preserve its effectiveness.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.